BioMed Realty Earns Upgraded Investment Grade Corporate Credit Rating From Standard & Poor's Ratings Services

  BioMed Realty Earns Upgraded Investment Grade Corporate Credit Rating From
                      Standard & Poor's Ratings Services

PR Newswire

SAN DIEGO, April 15, 2014

SAN DIEGO, April 15, 2014 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE:
BMR) today announced that its investment grade corporate credit rating from
Standard & Poor's Ratings Services ("S&P") has been upgraded from BBB– to BBB.
BioMed Realty was the first real estate investment trust dedicated to the life
science industry to receive investment grade corporate credit ratings from S&P
and Moody's Investors Service ("Moody's") in April 2010. The company received
positive outlooks from S&P and Moody's in June 2013 and March 2014,
respectively.

"We view our investment grade corporate credit rating as one of the key
drivers of our capital strategy and a competitive advantage in pursuing
strategic growth opportunities," said Greg N. Lubushkin, Chief Financial
Officer of BioMed Realty. "We are pleased that S&P has upgraded our rating to
BBB, which further enhances our long-term financial flexibility as we continue
to build on our proven track record of creating value for our tenant partners
and stockholders."

About BioMed Realty Trust

BioMed Realty, with its trusted expertise and valuable relationships, delivers
optimal real estate solutions for biotechnology and pharmaceutical companies,
scientific research institutions, government agencies and other entities
involved in the life science industry. BioMed Realty owns or has interests in
properties comprising approximately 17.3 million rentable square feet.
Additional information is available at www.biomedrealty.com. Follow us on
Twitter @biomedrealty.

This press release contains forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995 based on current
expectations, forecasts and assumptions that involve risks and uncertainties
that could cause actual outcomes and results to differ materially. These risks
and uncertainties include, without limitation: general risks affecting the
real estate industry (including, without limitation, the inability to enter
into or renew leases, dependence on tenants' financial condition, and
competition from other developers, owners and operators of real estate);
adverse economic or real estate developments in the life science industry or
the company's target markets; risks associated with the availability and terms
of financing, the use of debt to fund acquisitions, developments and other
investments, and the ability to refinance indebtedness as it comes due;
failure to maintain the company's investment grade credit ratings with the
ratings agencies; failure to manage effectively the company's growth and
expansion into new markets, or to complete or integrate acquisitions and
developments successfully; reductions in asset valuations and related
impairment charges; risks and uncertainties affecting property development and
construction; risks associated with tax credits, grants and other subsidies to
fund development activities; risks associated with downturns in foreign,
domestic and local economies, changes in interest rates and foreign currency
exchange rates, and volatility in the securities markets; ownership of
properties outside of the United States that subject the company to different
and potentially greater risks than those associated with the company's
domestic operations; risks associated with the company's investments in loans,
including borrower defaults and potential principal losses; potential
liability for uninsured losses and environmental contamination; risks
associated with the company's potential failure to qualify as a REIT under the
Internal Revenue Code of 1986, as amended, and possible adverse changes in tax
and environmental laws; and risks associated with the company's dependence on
key personnel whose continued service is not guaranteed. For a further list
and description of such risks and uncertainties, see the reports filed by the
company with the Securities and Exchange Commission, including the company's
most recent annual report on Form 10-K and quarterly reports on Form 10-Q. The
company disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise.

SOURCE BioMed Realty Trust, Inc.

Website: http://www.biomedrealty.com
Contact: Rick Howe, Senior Director, Corporate Communications, (858) 207-5859,
richard.howe@biomedrealty.com
 
Press spacebar to pause and continue. Press esc to stop.